Bio-Rad Labs Inc. A buy Citigroup Inc.
Start price
30.10.25
/
50%
€262.00
Target price
30.10.26
€322.88
Performance (%)
-0.46%
Price
02.06.26
€263.20
Summary
This prediction is currently active. Since the start of the prediction for Bio-Rad Labs Inc. A the price has only changed by -0.46%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Rad Labs Inc. A | 3.054% | 3.054% |
| iShares Core DAX® | -1.756% | 1.667% |
| iShares Nasdaq 100 | 2.324% | 12.779% |
| iShares Nikkei 225® | 5.022% | 13.300% |
| iShares S&P 500 | 0.802% | 6.198% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€329.60
31.10.24
31.10.24
€413.33
31.10.25
31.10.25
-16.99%
01.11.25
01.11.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€299.30
01.10.24
01.10.24
€361.20
01.10.25
01.10.25
-16.17%
02.10.25
02.10.25